Exercise, inflammation, and fatigue in cancer survivors

Exercise Immunology Review

Volumn 22, Issue , 2016, Pages 82-92

  LaVoy, Emily C P ^a   Fagundes, Christopher P ^b,c   Dantzer, Robert ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b RICE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; ALPHA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENINE; KYNURENINE AMINOTRANSFERASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEOPTERIN; SIRTUIN 1; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ALTERNATIVE MEDICINE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN FUNCTION; CANCER FATIGUE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOPULMONARY FUNCTION; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; EVIDENCE BASED MEDICINE; EXERCISE; FITNESS; HEART RATE VARIABILITY; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; MUSCLE STRENGTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOLOGICAL WELL BEING; SARCOPENIA; SELF CONCEPT; SIGNAL TRANSDUCTION;

EID: 84983459024     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (127)

1. Berger, A.M., et al., Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw, 2015. 13(8): p. 1012-39.
2. Barsevick, A.M., et al., Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst, 2013. 105(19): p. 1432-40.
3. Bennett, B., et al., The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study. J Pain Symptom Manage, 2007. 34(2): p. 126-35.
4. Cleeland, C.S., et al., Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 2003. 97(11): p. 2919-25.
5. Ganz, P.A., et al., Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst, 2002. 94(1): p. 39-49.
6. Lawrence, D.P., et al., Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr, 2004(32): p. 40-50.
7. Bower, J.E., Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol, 2014. 11(10): p. 597-609.
8. Groenvold, M., et al., Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat, 2007. 105(2): p. 209-19.
9. Prue, G., et al., Cancer-related fatigue: A critical appraisal. Eur J Cancer, 2006. 42(7): p. 846-63.
10. Bower, J.E., et al., Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer, 2006. 106(4): p. 751-8.
11. Jones, J.M., et al., Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv, 2015.
12. Dantzer, R., et al., The neuroimmune basis of fatigue. Trends Neurosci, 2014. 37(1): p. 39-46.
13. Glaus, A., R. Crow, and S. Hammond, A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. European journal of cancer care, 1996. 5(2 Suppl): p. 8-23.
14. Curt, G.A., et al., Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. The oncologist, 2000. 5(5): p. 353-60.
15. Sadler, I.J., et al., Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. Journal of pain and symptom management, 2002. 23(5): p. 406-16.
16. Van Belle, S., et al., Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005. 13(4): p. 246-54.
17. Mendoza, T.R., et al., The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer, 1999. 85(5): p. 1186-96.
18. Cleeland, C.S., et al., Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer, 2000. 89(7): p. 1634-46.
19. Dantzer, R., M.W. Meagher, and C.S. Cleeland, Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol, 2012. 9(7): p. 414-26.
20. Fagundes, C.P., et al., Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology, 2011. 36(8): p. 1137-47.
21. Berger, A.M., et al., Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer, 2010. 18(1): p. 105-14.
22. Courneya, K.S., Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc, 2003. 35(11): p. 1846-52.
23. McNeely, M.L., et al., Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ, 2006. 175(1): p. 34-41.
24. Bower, J.E., et al., Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med, 2002. 64(4): p. 604-11.
25. Alfano, C.M., et al., Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors. J Clin Oncol, 2012. 30(12): p. 1280-7.
26. Orre, I.J., et al., Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res, 2011. 71(3): p. 136-41.
27. Alexander, S., et al., A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer, 2009. 45(3): p. 384-92.
28. Landmark-Hoyvik, H., et al., Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J, 2009. 9(5): p. 333-40.
29. Reinertsen, K.V., et al., Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv, 2010. 4(4): p. 405-14.
30. Bower, J.E., et al., T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst, 2003. 95(15): p. 1165-8.
31. Collado-Hidalgo, A., et al., Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res, 2006. 12(9): p. 2759-66.
32. Schrepf, A., et al., Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability. Brain Behav Immun, 2013. 30 Suppl: p. S126-34.
33. Rausch, S.M., et al., Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer, 2010. 116(17): p. 4103-13.
34. Bower, J.E., et al., Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorti-coid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun, 2011. 25(1): p. 147-50.
35. Yount, S., et al., Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis. Clin Exp Rheuma-tol, 2007. 25(6): p. 838-46.
36. Tyring, S., et al., Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet, 2006. 367(9504): p. 29-35.
37. Felger, J.C. and A.H. Miller, Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol, 2012. 33(3): p. 315-27.
38. Dantzer, R., Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci, 2001. 933: p. 222-34.
39. Neurauter, G., et al., Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab, 2008. 9(7): p. 622-7.
40. Dantzer, R., et al., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci, 2008. 9(1): p. 46-56.
41. O'Connor, J.C., et al., Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol, 2009. 182(5): p. 3202-12.
42. O'Connor, J.C., et al., Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry, 2009. 14(5): p. 511-22.
43. Olsson, J., et al., Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev, 2000. 121(1-3): p. 187-201.
44. Walker, A.K., et al., NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology, 2013. 38(9): p. 1609-16.
45. Kurz, K., et al., Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown. PLoS One, 2012. 7(5): p. e36956.
46. Thayer, J.F. and R.D. Lane, The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol, 2007. 74(2): p. 224-42.
47. Stein, P.K. and R.E. Kleiger, Insights from the study of heart rate variability. Annu Rev Med, 1999. 50: p. 249-61.
48. Tak, L.M., et al., As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol, 2009. 82(2): p. 101-10.
49. Segerstrom, S.C. and L.S. Nes, Heart rate variability reflects self-regulatory strength, effort, and fatigue. Psychol Sci, 2007. 18(3): p. 275-81.
50. Egelund, N., Spectral analysis of heart rate variability as an indicator of driver fatigue. Ergonomics, 1982. 25(7): p. 663-72.
51. Hautala, A., et al., Changes in cardiac autonomic regulation after prolonged maximal exercise. Clin Physiol, 2001. 21(2): p. 238-45.
52. Lakoski, S.G., et al., Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms. Am Heart J, 2015. 170(2): p. 231-41.
53. Vigo, C., et al., Evidence of altered autonomic cardiac regulation in breast cancer survivors. J Cancer Surviv, 2015.
54. Crosswell, A.D., et al., Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroen-docrinology, 2014. 45: p. 58-66.
55. Tracey, K.J., Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest, 2007. 117(2): p. 289-96.
56. Nicolaides, N.C., et al., Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions. Ann N Y Acad Sci, 2014. 1318: p. 71-80.
57. MacHale, S.M., et al., Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology, 1998. 38(4): p. 213-7.
58. Bower, J.E., et al., Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology, 2005. 30(1): p. 92-100.
59. Bower, J.E., P.A. Ganz, and N. Aziz, Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med, 2005. 67(2): p. 277-80.
60. Ratnasingam, J., et al., Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary, 2015. 18(4): p. 448-55.
61. Hoyt, M.A., et al., Approach and avoidance coping: diurnal cortisol rhythm in prostate cancer survivors. Psychoneuroen-docrinology, 2014. 49: p. 182-6.
62. Follin, C., et al., Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia. Pituitary, 2014. 17(1): p. 7-12.
63. Al-Majid, S. and H. Waters, The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs, 2008. 10(1): p. 7-20.
64. Davis, M.P. and D. Walsh, Mechanisms of fatigue. J Support Oncol, 2010. 8(4): p. 164-74.
65. McMillan, E.M. and I.J. Newhouse, Exercise is an effective treatment modality for reducing cancer-related fatigue and improving physical capacity in cancer patients and survivors: a meta-analysis. Appl Physiol Nutr Metab, 2011. 36(6): p. 892-903.
66. McAuley, E., et al., Physical activity and fatigue in breast cancer and multiple sclerosis: psychosocial mechanisms. Psycho-som Med, 2010. 72(1): p. 88-96.
67. Knobel, H., et al., High level of fatigue in lymphoma patients treated with high dose therapy. J Pain Symptom Manage, 2000. 19(6): p. 446-56.
68. Dimeo, F., et al., Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol, 2004. 15(8): p. 1237-42.
69. Vyas, D., G. Laput, and A.K. Vyas, Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther, 2014. 7: p. 1015-23.
70. Lee, C.S., E.J. Ryan, and G.A. Doherty, Gastro-intestinal toxic-ity of chemotherapeutics in colorectal cancer: the role of inflammation. World J Gastroenterol, 2014. 20(14): p. 3751-61.
71. Sprung, C.N., et al., Immunological markers that predict radiation toxicity. Cancer Lett, 2015.
72. Bennett, G.J., T. Doyle, and D. Salvemini, Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neu-rol, 2014. 10(6): p. 326-36.
73. Bennett, G.J., Pathophysiology and animal models of cancer-related painful peripheral neuropathy. Oncologist, 2010. 15 Suppl 2: p. 9-12.
74. Krukowski, K., et al., Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-mu. Pain, 2015. 156(11): p. 2184-92.
75. Zheng, H., W.H. Xiao, and G.J. Bennett, Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol, 2011. 232(2): p. 154-61.
76. Minton, O., et al., A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst, 2008. 100(16): p. 1155-66.
77. Jacobsen, P.B., et al., Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol, 2007. 26(6): p. 660-7.
78. Duijts, S.F., et al., Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors-a meta-analysis. Psychooncology, 2011. 20(2): p. 115-26.
79. Kangas, M., D.H. Bovbjerg, and G.H. Montgomery, Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull, 2008. 134(5): p. 700-41.
80. Speed-Andrews, A.E. and K.S. Courneya, Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep, 2009. 8(4): p. 176-81.
81. Wolin, K.Y., et al., Exercise in adult and pediatric hematologi-cal cancer survivors: an intervention review. Leukemia, 2010. 24(6): p. 1113-20.
82. Brown, J.C., et al., Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 2011. 20(1): p. 123-33.
83. Mishra, S.I., et al., Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev, 2012. 8: p. CD007566.
84. Courneya, K.S., et al., Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopul-monary and quality of life outcomes. J Clin Oncol, 2003. 21(9): p. 1660-8.
85. Donnelly, C.M., et al., A randomised controlled trial testing the feasibility and efficacy of a physical activity behavioural change intervention in managing fatigue with gynaecological cancer survivors. Gynecol Oncol, 2011. 122(3): p. 618-24.
86. Speck, R.M., et al., An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analy-sis. J Cancer Surviv, 2010. 4(2): p. 87-100.
87. Schmitz, K.H., et al., American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc, 2010. 42(7): p. 1409-26.
88. McAuley, E. and B. Blissmer, Self-efficacy determinants and consequences of physical activity. Exerc Sport Sci Rev, 2000. 28(2): p. 85-8.
89. Phillips, S.M. and E. McAuley, Physical activity and fatigue in breast cancer survivors: a panel model examining the role of self-efficacy and depression. Cancer Epidemiol Biomarkers Prev, 2013. 22(5): p. 773-81.
90. Hartescu, I., K. Morgan, and C.D. Stevinson, Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial. J Sleep Res, 2015.
91. Al-Majid, S. and D.P. Gray, A biobehavioral model for the study of exercise interventions in cancer-related fatigue. Biol Res Nurs, 2009. 10(4): p. 381-91.
92. Gleeson, M., et al., The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol, 2011. 11(9): p. 607-15.
93. Petersen, A.M. and B.K. Pedersen, The anti-inflammatory effect of exercise. J Appl Physiol (1985), 2005. 98(4): p. 1154-62.
94. Plaisance, E.P. and P.W. Grandjean, Physical activity and high-sensitivity C-reactive protein. Sports Med, 2006. 36(5): p. 443-58.
95. Battaglini, C.L., et al., The effects of an exercise program in leukemia patients. Integr Cancer Ther, 2009. 8(2): p. 130-8.
96. Rogers, L.Q., et al., Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther, 2013. 12(4): p. 323-35.
97. Fairey, A.S., et al., Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun, 2005. 19(5): p. 381-8.
98. Jones, S.B., et al., Effect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study. Cancer Prev Res (Phila), 2013. 6(2): p. 109-18.
99. Kiecolt-Glaser, J.K., et al., Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol, 2014. 32(10): p. 1040-9.
100. Bower, J.E., et al., Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology, 2014. 43: p. 20-9.
101. Allgayer, H., S. Nicolaus, and S. Schreiber, Decreased inter-leukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment. Cancer Detect Prev, 2004. 28(3): p. 208-13.
102. Hutnick, N.A., et al., Exercise and lymphocyte activation following chemotherapy for breast cancer. Med Sci Sports Exerc, 2005. 37(11): p. 1827-35.
103. Nolan, R.P., et al., Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. Eur J Cardiovasc Prev Rehabil, 2008. 15(4): p. 386-96.
104. Seals, D.R. and P.B. Chase, Influence of physical training on heart rate variability and baroreflex circulatory control. J Appl Physiol (1985), 1989. 66(4): p. 1886-95.
105. Levy, W.C., et al., Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol, 1998. 82(10): p. 1236-41.
106. Niederer, D., et al., Exercise effects on HRV in cancer patients. Int J Sports Med, 2013. 34(1): p. 68-73.
107. Pawelec, G., et al., Cytomegalovirus and human immunose-nescence. Rev Med Virol, 2009. 19(1): p. 47-56.
108. Ness, K.K., et al., Frailty in childhood cancer survivors. Cancer, 2015. 121(10): p. 1540-7.
109. Tchkonia, T., et al., Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest, 2013. 123(3): p. 966-72.
110. Hassan, I.S., et al., A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol, 1998. 87(1): p. 60-7.
111. Spielmann, G., et al., Aerobic fitness is associated with lower proportions of senescent blood T-cells in man. Brain Behav Immun, 2011. 25(8): p. 1521-9.
112. Simpson, R.J., Aging, persistent viral infections, and immunosenescence: can exercise "make space"? Exerc Sport Sci Rev, 2011. 39(1): p. 23-33.
113. Kohman, R.A., et al., Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice. J Neuroinflammation, 2013. 10: p. 114.
114. Masson, G.S., et al., Aerobic training normalizes autonomic dysfunction, HMGB1 content, microglia activation and inflammation in hypothalamic paraventricular nucleus of SHR. Am J Physiol Heart Circ Physiol, 2015. 309(7): p. H1115-22.
115. Cotman, C.W. and C. Engesser-Cesar, Exercise enhances and protects brain function. Exerc Sport Sci Rev, 2002. 30(2): p. 75-9.
116. Yau, S.Y., et al., Physical exercise-induced hippocampal neu-rogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin. Proc Natl Acad Sci U S A, 2014. 111(44): p. 15810-5.
117. Kriketos, A.D., et al., Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care, 2004. 27(2): p. 629-30.
118. Hennings, A., et al., Exercise affects symptom severity but not biological measures in depression and somatization - results on IL-6, neopterin, tryptophan, kynurenine and 5-HIAA. Psychiatry Res, 2013. 210(3): p. 925-33.
119. Agudelo, L.Z., et al., Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell, 2014. 159(1): p. 33-45.
120. Handschin, C. and B.M. Spiegelman, The role of exercise and PGC1alpha in inflammation and chronic disease. Nature, 2008. 454(7203): p. 463-9.
121. Mahoney, D.J. and M.A. Tarnopolsky, Understanding skeletal muscle adaptation to exercise training in humans: contributions from microarray studies. Phys Med Rehabil Clin N Am, 2005. 16(4): p. 859-73, vii.
122. Sanchis-Gomar, F., C.P. Quilis, and A. Lucia, Antidepressant Effects of Exercise: A Role for the Adiponectin-PGC-1alpha-kynurenine Triad? J Cell Physiol, 2015. 230(10): p. 2328-9.
123. Villena, J.A., New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond. FEBS J, 2015. 282(4): p. 647-72.
124. Lucia, A., C. Earnest, and M. Perez, Cancer-related fatigue: can exercise physiology assist oncologists? Lancet Oncol, 2003. 4(10): p. 616-25.
125. Eickmeyer, S.M., et al., The role and efficacy of exercise in persons with cancer. PM R, 2012. 4(11): p. 874-81.
126. Treadway, M.T. and D.H. Zald, Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev, 2011. 35(3): p. 537-55.
127. Dobryakova, E., et al., The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front Neurol, 2015. 6: p. 52.